{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:17:58Z","timestamp":1787771878314,"version":"build-2784847793"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Distinguishing T-lymphoblastic leukemia\/lymphoma (T-ALL\/T-LBL) from thymomas (especially B1 or B2 type) can be challenging particularly in limited trucut biopsy material where appreciating architecture is difficult or the background epithelial component does not provide tangible evidence for definite diagnosis. As a pathologist, it is important to accurately diagnose these neoplasms because they have entirely distinct management protocols. Recent studies have reported that LIM Domain Only 2 (LMO2) is expressed in neoplastic lymphoblasts of T-ALL\/T-LBL and is absent in thymocytes of normal thymuses or thymomas. An observational study was done to test the sensitivity and specificity of LMO2 in differentiating neoplastic lymphoblasts from thymocytes of thymomas\/normal thymuses. Our study showed that LMO2 had sensitivity of 70% and specificity of 100% in diagnosing LBL. None of the thymomas (B1 or B2 type) showed expression of LMO2 in the neoplastic cells. LMO2 is a reliable marker of transformed T-cell precursors and should be routinely included in immunohistochemical panel when evaluating thymic\/mediastinal neoplasms.<\/jats:p>","DOI":"10.4103\/ijpm.ijpm_111_23","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T15:03:05Z","timestamp":1707750185000},"page":"141-144","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia\/lymphoma from thymoma"],"prefix":"10.4103","volume":"67","author":[{"given":"Divya","family":"Bansal","sequence":"first","affiliation":[{"name":"Department of Pathology, Molecular Diagnostics and Transfusion Services, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Pasricha","sequence":"additional","affiliation":[{"name":"Department of Pathology, Molecular Diagnostics and Transfusion Services, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurudutt","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pathology, Molecular Diagnostics and Transfusion Services, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anila","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pathology, Molecular Diagnostics and Transfusion Services, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Durga","sequence":"additional","affiliation":[{"name":"Department of Pathology, Molecular Diagnostics and Transfusion Services, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Kamboj","sequence":"additional","affiliation":[{"name":"Department of Pathology, Molecular Diagnostics and Transfusion Services, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Laboratory Services, Molecular Diagnostics and Transfusion Services, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ajcp\/aqv024","article-title":"LMO2 Is a specific marker of T-lymphoblastic leukemia\/lymphoma","volume":"145","author":"Jevremovic","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jclinpath-2018-205399","article-title":"Distinguishing thymoma from T-lymphoblastic leukaemia\/lymphoma:A case-based evaluation","volume":"72","author":"Boddu","year":"2019","journal-title":"J Clin Pathol"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/PAI.0000000000000107","article-title":"Diagnostic utility of the germinal center-associated markers GCET1, HGAL, and LMO2 in hematolymphoid neoplasms","volume":"23","author":"Menter","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.prp.2015.06.002","article-title":"Concurrent thymoma, thymic carcinoma, and T lymphoblastic leukemia\/lymphoma in an anterior mediastinal mass","volume":"211","author":"Ito","year":"2015","journal-title":"Pathol Res Pract"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","article-title":"T-cell acute lymphoblastic leukemia in adults:Clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993)","volume":"114","author":"Marks","year":"2009","journal-title":"Blood"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/JTO.0b013e3181a4b8e0","article-title":"The management of thymoma:A systematic review and practice guideline","volume":"4","author":"Falkson","year":"2009","journal-title":"J Thorac Oncol"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","article-title":"T-lymphoblastic leukemia\/lymphoma","volume":"144","author":"You","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/10428190310001598008","article-title":"Flow cytometry in the diagnosis of mediastinal tumors with emphasis on differentiating thymocytes from precursor T-lymphoblastic lymphoma\/leukemia","volume":"45","author":"Gorczyca","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2559.2012.04198.x","article-title":"Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody","volume":"61","author":"Agostinelli","year":"2012","journal-title":"Histopathology"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1309\/AJCP5FP3NAXAXRJE","article-title":"The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities","volume":"131","author":"Gratzinger","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"R11-20240829","first-page":"853","article-title":"The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice","volume":"11","author":"Larson","year":"1995","journal-title":"Oncogene"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1182378","article-title":"The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal","volume":"327","author":"McCormack","year":"2010","journal-title":"Science"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.leu.2404957","article-title":"Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences","volume":"22","author":"van Grotel","year":"2008","journal-title":"Leukemia"},{"key":"R14-20240829","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/path.2789","article-title":"Notch signalling in T-cell lymphoblastic leukaemia\/lymphoma and other haematological malignancies","volume":"223","author":"Aster","year":"2011","journal-title":"J Pathol"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/PAS.0000000000000358","article-title":"NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T-lymphoblastic lymphoma from thymoma","volume":"39","author":"Jegalian","year":"2015","journal-title":"Am J Surg Pathol"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpm.ijpm_111_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:19:26Z","timestamp":1787768366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpm.ijpm_111_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_111_23","relation":{},"ISSN":["0377-4929","0974-5130"],"issn-type":[{"value":"0377-4929","type":"print"},{"value":"0974-5130","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"assertion":[{"value":"2023-02-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}